US Corporate Distress Financial Stress SEC Filings — April 10, 2026

10-04-2026

Snail, Inc. amended its ARK1 License Agreement with related party SDE Inc., reducing monthly licensing fees from $2 million to $1.5 million (a 25% decrease) until the ARK 2 release, while maintaining $5 million one-time payments for certain DLCs with some exclusions. The company also entered a new Software Development Outsourcing Agreement with related party Suzhou Snail for Project Aether, committing to total payments of $1.966 million in four quarterly installments of $491,500 starting Q2 2026. Both agreements involve entities controlled or directed by CEO Hai Shi and director Ying Zhou.

• ·ARK1 License Agreement originally dated January 1, 2022, previously amended December 13, 2022, March 10, 2023, and October 1, 2023.
• ·Outsourcing Agreement provides Company retains all IP rights for Project Aether.
• ·Agreements dated April 6, 2026; Amendment effective April 1, 2026.

10-04-2026

Hecla Mining Company completed the full redemption of its remaining $263 million 7.25% Senior Notes due 2028, achieving an unencumbered balance sheet and unlocking full capital flexibility for strategic growth investments. The redemption was funded by cash proceeds from the recently completed Casa Berardi sale and cash on hand. This milestone strengthens the company's financial position amid compelling silver market dynamics.

• ·Founded in 1891, Hecla is the largest silver producer in the United States and Canada.
• ·Operates mines in Alaska and Idaho, ramping up a mine in the Yukon, Canada.
• ·Owns exploration and pre-development projects in North American silver and gold districts.
• ·References 2025 Form 10-K filed on February 18, 2026.

10-04-2026

Annovis Bio, Inc. (NYSE: ANVS) announced the pricing of a $10 million underwritten offering of 5,263,156 shares of common stock at $1.90 per share combined with accompanying warrants exercisable at $2.50 per share, expected to close on or about April 10, 2026. The net proceeds will fund the Phase 3 clinical development of buntanetap for Alzheimer's disease, working capital, and general corporate purposes. No declines or flat metrics reported in this financing announcement.

• ·Warrants exercisable commencing six months after issuance and expire five years and six months after issuance.
• ·Offering pursuant to shelf registration on Form S-3 (No. 333-276814), filed February 1, 2024, effective February 12, 2024.
• ·Canaccord Genuity acting as sole bookrunner.

10-04-2026

Beneficient (CIK: 0001775734), a finance services company (SIC: 6199) incorporated in NV with fiscal year end March 31, filed an 8-K on April 10, 2026, covering Items 3.02 (unregistered sales of equity securities), 3.03 (material modifications to rights of security holders), 5.03 (amendments to charter/bylaws), 7.01 (Regulation FD disclosure), and 9.01 (exhibits). The filing is categorized as Charter/Bylaws Amendments and a material event, with a file size of 3 MB. No financial figures, period comparisons, or performance metrics are detailed in the provided EDGAR listing.

• ·Company address: 325 N. Saint Paul Street, Suite 4850, Dallas, TX 75201
• ·Former name: Beneficient Co Group, L.P. (through 2023-05-16)

10-04-2026

CoreCivic, Inc. entered into the Second Amendment to its Fourth Amended and Restated Credit Agreement dated April 10, 2026, increasing the revolving credit facility limit from $300,000,000 to $400,000,000 and the incremental term loan capacity from $300,000,000 to $400,000,000. The amendment provides for a new $100,000,000 Incremental Term Loan-1 (fully drawn on the effective date), maturing April 9, 2027, with variable interest rates based on leverage (initially Pricing Level IV: Term SOFR + 3.25% or Base Rate + 2.25%), for working capital, general corporate purposes, Permitted Acquisitions, and revolver repayments. The company certified pro forma compliance with financial covenants, with no defaults or events of default.

• ·Amendment effective April 10, 2026, upon satisfaction of conditions including executed documents, officer's compliance certificate, legal opinions, no defaults, and payment of fees.
• ·Incremental Term Loan-1 terms identical to Initial Term Loan except maturity (April 9, 2027), pricing grid, and single draw with no prepayment penalty.
• ·Pricing grid steps down with lower Consolidated Total Leverage Ratio; initial Pricing Level IV until post-June 30, 2026 fiscal quarter.

10-04-2026

Delek US Holdings, Inc. and its subsidiaries entered into Amendment No. 4 to the Third Amended and Restated Credit Agreement originally dated October 26, 2022, effective April 9, 2026, with lenders and Wells Fargo Bank, National Association, as administrative agent. The amendment updates certain terms, deletes or restates multiple schedules (e.g., Commitments, Permitted Investments, Litigation), and adds a new schedule on Transactions with Affiliates, while confirming no Event of Default exists post-amendment. Conditions to effectiveness include perfected security interests, solvency certification, and a Borrowing Base Certificate, with no specific changes to borrowing capacity or financial metrics disclosed.

• ·Amendment updates Schedules including C-1 (Commitments), P-1 (Permitted Investments), P-2 (Permitted Liens), and adds new Schedule 5.13(e) (Transactions with Affiliates).
• ·Exhibits amended: C-1 (Compliance Certificate), J-1 (Borrower Joinder), J-2 (Guarantor Joinder), P-1 (Perfection Certificate).
• ·Legal opinions provided by Willkie Farr & Gallagher LLP and PPGMR Law, PLLC.

10-04-2026

Dynamix Corporation (SPAC) and parties including The Ether Machine, Inc., ETH Partners LLC, and DynamixCore Holdings, LLC terminated the July 21, 2025 Business Combination Agreement effective April 8, 2026, nullifying the proposed merger. As consideration, the Payor will pay SPAC exactly $50 million within 15 days, representing full compromise of all claims. Mutual broad releases are granted alongside cross-indemnification obligations, though the deal's failure halts the business combination.

• ·Certain sections of Business Combination Agreement survive termination: 8.13 (Public Announcements), 8.14 (Confidential Information), 10.2 (Effect of Termination), 11.1 (Waiver of Claims Against Trust), and Article XII (Miscellaneous)
• ·Payor indemnifies SPAC released persons against claims from non-SPAC ETHM Investors; SPAC indemnifies against shareholder claims (excluding ETHM Investors)
• ·Each party responsible for own attorneys' fees; mutual tax indemnity for taxes on the Payment

10-04-2026

Spire Global, Inc. (NYSE: SPIR) announced a $70.0 million private placement, selling 5.0 million shares of Class A common stock at $14.00 per share, with gross proceeds before fees and expenses, expected to close on or about April 10, 2026. Net proceeds will support working capital, general corporate purposes, growth in U.S. and international space reconnaissance, government weather data procurement, sales and marketing enhancement, RF geolocation and weather tech deployment, and cyber security improvements. Craig-Hallum Capital Group LLC served as the sole placement agent.

• ·Private placement is not a public offering; securities unregistered under Securities Act of 1933.
• ·Company to file SEC registration statement for resale of shares pursuant to registration rights agreement.
• ·Filing date: April 10, 2026; announcement date: April 9, 2026.

10-04-2026

CV Sciences, Inc. entered into a Senior Secured Convertible Note with a principal amount of $99,614.04 issued on April 6, 2026, maturing on July 6, 2027, which is convertible into shares of common stock but accrues no interest unless an Event of Default occurs. This note supplements prior issuances including the First Note of $1,536,000 due February 12, 2027, and the Second Note of $720,000 due April 6, 2027. The agreement includes standard provisions for conversions, defaults, and permitted indebtedness.

• ·Mandatory Default Amount: 120% of outstanding principal and interest for major Events of Default; 105% for immaterial representation breaches.
• ·Permitted Indebtedness includes up to $50,000 aggregate for lease/purchase money and certain ordinary course items.
• ·Note issued under exemption from Securities Act registration; transferable only per Purchase Agreement dated February 12, 2025.

10-04-2026

Donaldson Company, Inc. entered into a Term Loan Credit Agreement dated April 8, 2026, with Wells Fargo Bank, National Association as Administrative Agent, U.S. Bank National Association as Syndication Agent, and other lenders party thereto, to provide credit extensions primarily for the Facet Acquisition. The availability period begins on the closing date and ends on the earliest of the Facet Acquisition Agreement termination, consummation of the acquisition, commitment termination, or October 31, 2026, with possible extensions to an Extended Availability Expiration Date not later than April 29, 2027 upon payment of an extension fee. Interest rates are tiered based on the Leverage Ratio, starting at Pricing Level 2 (0.100% Ticking Fee, 1.000% Term SOFR Loans, 0.000% Base Rate Loans), adjusting quarterly.

• ·Availability Period Extension possible upon payment of Availability Period Extension Fee, up to April 29, 2027 maximum
• ·Pricing Levels adjust 45 days (90 days for fiscal year-end) after each fiscal quarter based on Leverage Ratio; defaults to Level 6 if reporting delayed
• ·Audited Financial Statements reference fiscal year ended July 31, 2025

10-04-2026

Aebi Schmidt Holding AG amended its Relationship Agreement with PCS Holding AG and Peter Spuhler on April 7, 2026, adjusting director nomination rights based on the PCS Parties' ownership: three directors if ≥35%, two if ≥25% or ≥15%, and one if ≥12.5%. The amendment also allows the CEO to serve as Board Chair. This governance update follows the original agreement dated July 1, 2025.

• ·Original Relationship Agreement entered on July 1, 2025.
• ·8-K filed on April 10, 2026.

10-04-2026

On April 10, 2026, WidePoint Corporation entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC, enabling the potential issuance and sale of common stock with an aggregate offering price of up to $15.5 million through ATM methods. Net proceeds, if any, will support general corporate purposes such as business expansion, acquisitions, and other opportunities. The Sales Agent will receive up to 3.0% of gross proceeds as commission, with no obligation to conduct any sales.

• ·Sales may be made via methods defined as 'at the market offering' under Rule 415, using the agent's normal trading practices.
• ·Agreement terminates upon sale of all shares or as otherwise provided therein.
• ·Opinion and consent of Foley & Lardner LLP filed as Exhibits 5.1 and 23.1 regarding share validity.

10-04-2026

Everspin Technologies announced a strategic 10-year manufacturing agreement (extendable in 2-year increments) with Microchip Technology to expand onshore production capacity for MRAM and TMR sensor products at a Microchip facility in Oregon, with first products expected to ship in the second half of 2027. This partnership enhances supply chain resilience, supports growth plans, and provides ITAR-compliant processing while Everspin retains IP ownership and continues operations in Chandler, AZ. No financial terms were disclosed.

• ·Agreement leverages Everspin's Chandler, AZ facility (co-located at NXP) as benchmark for process installation at Microchip's Oregon Fab.
• ·Everspin to establish 'copy exact (plus)' MRAM line using Microchip's foundry services.
• ·Forward-looking statements reference risks in 10-K for year ended December 31, 2025, filed March 5, 2026.

10-04-2026

AIM ImmunoTech Inc. entered into the First Amendment to its Equity Distribution Agreement with Maxim Group LLC, dated April 1, 2025, effective April 10, 2026, removing the prior $3.0 million aggregate offering price limit on at-the-market sales of common stock. Sales are now capped only by the Maximum Amount defined by registered shares, authorized but unissued shares, and Form S-3 eligibility requirements. The amendment also updates the agreement title, introductory paragraph, counsel references, termination provisions, and notice details.

• ·Common stock sales limited by: (a) registered amount on Registration Statement, (b) authorized but unissued shares under Amended and Restated Certificate of Incorporation, (c) Form S-3 eligibility (General Instruction I.B.6 if applicable)
• ·Legal counsel updates: Thompson Hine LLP (Company counsel), Studebaker & Brackett PC (IP counsel), Ellenoff Grossman & Schole LLP (Agent counsel)

10-04-2026

Cantor Fitzgerald Income Trust, Inc. classified 920,000 authorized but unissued shares of preferred stock as 9.50% Series A Cumulative Redeemable Preferred Stock with a $25.00 liquidation preference per share via board resolutions. Holders are entitled to cumulative cash dividends of $2.375 per share annually (9.50% rate), payable quarterly in arrears starting July 31, 2026, for the initial period from the Original Issue Date through July 30, 2026. The series includes redemption rights, conversion upon change of control, and other protective provisions.

• ·Quarterly dividend payment dates: last day of January, April, July, October (or next business day), commencing July 31, 2026.
• ·Series A Record Dates: January 15th, April 15th, July 15th, October 15th.
• ·Initial dividend prorated for partial period based on 360-day year of twelve 30-day months.

10-04-2026

NEONC Technologies Holdings, Inc. (NTHI) entered into an Equity Distribution Agreement with BTIG, LLC and A.G.P./Alliance Global Partners on April 10, 2026, to establish an at-the-market (ATM) equity offering program for up to $75,000,000 of its common stock (par value $0.0001 per share). The placement agents will earn a 3.0% commission on sales, with the offering conducted via the effective Form S-3 registration (File No. 333-294845, effective April 9, 2026) and a prospectus supplement filed on April 10, 2026. The program can be suspended or terminated by the company with two days' notice.

• ·Agreement terminable by company with two days' notice or by agents with one day's notice.
• ·Sales methods include at-the-market offerings on Nasdaq Global Market; alternative methods require prospectus supplement.
• ·Company is an emerging growth company.
• ·Legal opinion from Manatt, Phelps & Phillips, LLP attached as Exhibit 5.1.

10-04-2026

DevvStream Corp. received a Nasdaq notice on April 7, 2026, indicating non-compliance with Listing Rule 5450(a)(1) as its common shares (DEVS) closed below the $1.00 minimum bid price for 30 consecutive business days from February 23 to April 6, 2026. Due to a prior reverse stock split within the last year, the company is ineligible for a standard compliance period under Rule 5810(c)(3)(A)(iv) and faces potential suspension or delisting unless it requests a hearing. The company intends to timely request a hearing, which would stay delisting pending the Panel's decision, though success is not assured.

• ·Nasdaq Listing Rule 5450(a)(1): Minimum $1.00 bid price requirement.
• ·Nasdaq Listing Rule 5810(c)(3)(A)(iv): No compliance period due to recent reverse stock split.
• ·Company is an emerging growth company.
• ·Principal executive offices: 2108 N St., Suite 4254, Sacramento, California 95816.

10-04-2026

On April 7, 2026, Beyond Air, Inc. received a Nasdaq notice stating it no longer complies with the $1.00 minimum bid price rule (Nasdaq Listing Rule 5550(a)(2)) based on closing bid prices over 30 consecutive business days from February 23 to April 6, 2026. Due to a prior 1-for-20 reverse stock split on July 14, 2025, the company is ineligible for a 180-day compliance period and faces delisting unless it requests a hearing by April 14, 2026. The company plans to appeal, monitor its stock price, and consider options like another reverse split, though success is uncertain and there are no assurances of regaining compliance.

• ·Nasdaq Listing Rule 5810(c)(3)(A) defines bid price deficiency as continuing for 30 consecutive business days.
• ·Company address: 900 Stewart Avenue, Suite 301, Garden City, NY 11530.
• ·Commission File Number: 001-38892; I.R.S. Employer Identification No.: 47-3812456.

10-04-2026

Caring Brands, Inc. received a Nasdaq Staff Delisting Determination on April 7, 2026, for failing to comply with Listing Rule 5550(b)(1), reporting stockholders’ equity of $2,091,324 as of December 31, 2025, below the required $2.5 million minimum, and not meeting alternative standards of $35 million market value of listed securities or $500,000 net income. The company has 45 calendar days until May 22, 2026, to submit a compliance plan, with potential extension up to 180 days until October 4, 2026, if accepted. CABR common stock continues trading on Nasdaq unaffected immediately, but faces delisting risk if compliance is not regained.

• ·Emerging growth company status confirmed.
• ·Commission File Number: 001-42941; IRS Employer Identification No.: 99-4103908.
• ·Principal executive offices: 130 S Indian River Drive, Suite 202 pbm# 1232, Fort Pierce, FL 34950; Telephone: (561) 896-7616.

10-04-2026

Alpha Modus Holdings, Inc. entered into an Exchange Agreement on April 8, 2026, with the family trust of CEO William Alessi to exchange 3,870,000 Series C Preferred Shares for 109,588,265 Class A Common Shares, intended to increase market value to regain Nasdaq MVLS compliance and reduce stockholders’ deficit. However, on April 6, 2026, the company received a Nasdaq notice stating it fails the $500,000 minimum net income standard, $35 million MVLS Standard, or $2.5 million stockholders’ equity requirement, posing delisting risk despite no immediate trading impact. The exchange awaits shareholder approval under Nasdaq Rule 5635 and includes a lock-up on Common Shares until June 13, 2026.

• ·Company has 45 days from April 6, 2026, to submit a compliance plan to Nasdaq, with potential 180-day extension if accepted.
• ·Common Shares to be issued in reliance on Section 3(a)(9) exemption of the Securities Act.
• ·Exchange calculated based on conversion terms in Company’s Certificate of Incorporation as if convertible prior to June 13, 2026.

10-04-2026

GM Financial Consumer Automobile Receivables Trust 2026-2, sponsored by AmeriCredit Financial Services, Inc. d/b/a GM Financial, will issue $1,269,810,000 in asset-backed notes across multiple classes (A-1 through C) backed by prime consumer automobile loan receivables secured by new and used vehicles, with closing on April 15, 2026. The notes carry fixed rates from 3.826% to 4.64% (and one floating rate class), sold via underwriters led by J.P. Morgan Securities LLC pursuant to key agreements filed as exhibits. No performance declines or flat metrics are reported in this new issuance filing.

• ·Underwriting Agreement dated April 8, 2026, among GM Financial, AFS SenSub, and J.P. Morgan as Representative.
• ·Indenture dated April 15, 2026, between Issuing Entity and The Bank of New York Mellon as Trustee and Trust Collateral Agent.
• ·Trust Agreement dated February 27, 2026, as amended and restated April 15, 2026, between AFS SenSub and Wilmington Trust Company as Owner Trustee.
• ·Sale and Servicing Agreement dated April 15, 2026, with GM Financial as Servicer.
• ·Clayton Fixed Income Services LLC engaged as Asset Representations Reviewer.

10-04-2026

NextNRG, Inc. entered into a Securities Purchase Agreement dated April 1, 2026, with Leviston Resources, LLC, for the sale of a Senior Secured Convertible Promissory Note with a principal amount of $1,724,444 (including $172,444 OID, for a purchase price of $1,552,000) and 243,300 shares of common stock as additional consideration. The closing occurred on April 1, 2026, at 4:00 PM Eastern Time, with the transaction relying on exemptions under Section 4(a)(2) of the Securities Act and Rule 506(b). No operational or financial performance metrics were disclosed.

• ·Agreement executed under exemption of Section 4(a)(2) of the Securities Act and Rule 506(b).
• ·Closing via exchange of electronic signatures or mutually agreed location.
• ·Note is senior secured; includes representations on organization, authorization, capitalization, and compliance.

10-04-2026

Callan JMB Inc. received a deficiency notice from Nasdaq on April 7, 2026, for failing to maintain the minimum $2,500,000 stockholders’ equity required under Listing Rule 5550(b)(1), posing a delisting risk. The company has 45 days until May 22, 2026, to submit a compliance plan, with potential extension to October 4, 2026, if accepted by Nasdaq. Trading of common stock (CJMB) continues unaffected immediately, but there is no assurance of regaining compliance.

• ·Common Stock: $0.001 par value, trading symbol CJMB on The Nasdaq Capital Market
• ·Company is an emerging growth company
• ·Principal executive offices: 244 Flightline Drive, Spring Branch, Texas 78070

10-04-2026

On April 7, 2026, HyOrc Corporation entered into a Novation and Assignment Agreement with Start Lda and MO.RE.DA. Oils, Lda, under which MO.RE.DA. Oils assumes all rights and obligations as the 50% joint venture partner in HyOrc Start Green Fuels, Lda, replacing Start Lda, with ownership structure unchanged at 50% each. MO.RE.DA. Oils committed to providing land, infrastructure, permitting support, and its existing permitted industrial facility in Guilhabreu, Vila do Conde, Portugal, for the waste-to-methanol pilot plant, potentially shortening development via permit amendment rather than full greenfield process. No financial terms or changes in ownership percentages were disclosed.

• ·Novation and Assignment Agreement dated April 7, 2026 (Exhibit 9.1)
• ·Industrial facility located in Guilhabreu, Vila do Conde, Portugal, with existing operating permit

10-04-2026

BOXABL Inc. filed an 8-K on April 10, 2026, disclosing entry into a material definitive agreement under Item 1.01 and providing financial statements and exhibits under Item 9.01. No specific details on the agreement, financial figures, or performance metrics are available in the provided filing index. The filing size is 2 MB, indicating potential exhibits or attachments.

• ·Filing CIK: 0001816937
• ·SIC: 1520 (GEN BUILDING CONTRACTORS - RESIDENTIAL BUILDINGS)
• ·Business Address: 5345 E. N. BELT ROAD, NORTH LAS VEGAS NV 89115

10-04-2026

Healthcare Triangle, Inc. (HCTI) entered into a Platform Development Agreement effective March 31, 2026, with SecureKloud Technologies Limited (SKL) as lead contractor and Blockedge Technologies Inc. as subcontractor, to design, develop, test, and deliver an integrated health advisory and care platform including document management AI tools, with HCTI owning all IP rights exclusively. The project has a $3.0 million budget plus $0.2 million contingency (any overruns beyond $3.2 million require HCTI pre-approval), and no further payments will be made until prior advances of $3.48 million to SKL and $0.345 million to Blockedge are fully offset against invoices. The project term is 12-15 months, completing no later than September 30, 2027.

• ·Agreement supplements and amends prior master services agreements dated April 1, 2023 and January 1, 2025.
• ·SKL to issue monthly invoices by the 5th working day for preceding month's services, inclusive of transfer pricing and taxes, offsettable against advances at HCTI's discretion.
• ·Platform deployable globally by HCTI without SKL or Blockedge approval, primarily targeting North American and European markets.

10-04-2026

SCWorx Corp. was notified by Nasdaq on April 7, 2026, that it failed to regain compliance with the $1 minimum bid price rule after a 180-day extension, leading to suspension of trading on April 14, 2026, and filing of Form 25-NSE. The company appealed the delisting determination and effected a 1-for-15 reverse stock split on April 10, 2026, requiring the stock to trade at or above $1 for 10 consecutive days to potentially regain compliance. However, success is not assured, which could adversely impact the company.

• ·Initial noncompliance notification on April 10, 2025, based on closing bid price for 30 consecutive business days from February 26, 2025, through April 9, 2025.
• ·180-day compliance extension granted on October 8, 2025, expiring April 6, 2026.
• ·Former company name: Alliance MMA, Inc. (changed May 10, 2016).

10-04-2026

Focus Universal Inc. (NASDAQ: FCUV) announced a $4.0 million private placement with institutional investors, priced at the market under Nasdaq rules at $3.58 per Common Unit, consisting of 1,117,318 Common Units (or Pre-Funded Units) including Series A and B PIPE warrants exercisable at $3.33 per share. Gross proceeds are expected to fund general corporate purposes and working capital, with closing anticipated on or about April 7, 2026. Aegis Capital Corp. acted as exclusive placement agent.

• ·Series A PIPE Common Warrants expire 24 months after issuance; Series B expire 60 months after issuance.
• ·Pre-Funded Warrants are immediately exercisable at $0.00001 per share.
• ·Securities sold in private placement to accredited investors; registration rights agreement for resale.
• ·Press release dated April 6, 2026; SEC filing dated April 10, 2026.

10-04-2026

AppTech Payments Corp., a Delaware corporation, entered into a Securities Purchase Agreement dated 2026 with an undisclosed Buyer for the issuance and sale of a Note and Warrants, relying on the Section 4(a)(2) exemption under the 1933 Act and Rule 506(b). The agreement outlines covenants including the purchase of D&O insurance within 60 days of closing for 18 months coverage with a two-year tail, irrevocable transfer agent instructions for share issuances, and conditions to closing such as accurate representations and no material adverse events. No purchase price, note principal, or other financial amounts are specified in the provided exhibit.

• ·Agreement provides for arbitration of claims in San Diego County, California, under Delaware law.
• ·Company warrants no other instructions to transfer agent conflicting with Irrevocable Transfer Agent Instructions.
• ·Conditions to Buyer's obligation include no suspension of trading in Common Stock and timely 1934 Act reporting.

10-04-2026

RELIABILITY INC (RLBY) filed an 8-K on April 10, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or performance details were provided in the filing metadata.

• ·Filing accession number: 0001493152-26-016224
• ·File size: 3 MB
• ·CIK: 0000034285
• ·SIC: 7363 (SERVICES-HELP SUPPLY SERVICES)
• ·State of Incorporation: TX
• ·Fiscal Year End: December 31

10-04-2026

Lyra Therapeutics, Inc. terminated its lease for 22,343 rentable square feet at 480 Arsenal Way, Watertown, MA, originally expiring April 30, 2027, by forfeiting a $302,514.84 security deposit and paying $1,000,000, with a potential additional payment of up to $1,500,000 upon a Sale Transaction; rent obligations ended January 31, 2026. Separately, it terminated its lease for 28,858 rentable square feet at 880 Winter Street, Waltham, MA, originally expiring June 30, 2033, by forfeiting a $1,089,389 security deposit and paying a $1,500,000 termination fee, with rent obligations ending March 31, 2026. Both leases terminate no later than May 31, 2026, incurring immediate costs exceeding $4.4 million in total payments and forfeitures but eliminating long-term rent liabilities.

• ·480 Arsenal Way lease originally scheduled to expire April 30, 2027; rent obligations terminated January 31, 2026.
• ·880 Winter Street lease originally scheduled to expire June 30, 2033; rent obligations terminated March 31, 2026; includes mutual releases effective termination date.
• ·Termination agreements dated March 31, 2026 (Arsenal Way) and April 7, 2026 (Winter Street); 8-K filed April 10, 2026.

10-04-2026

Upland Software, Inc. received a Nasdaq notification on April 7, 2026, stating that its common stock closing bid price was below the $1.00 minimum for 30 consecutive business days, violating Listing Rule 5450(a)(1). The company has 180 days until October 5, 2026, to regain compliance by sustaining a $1.00 closing price for 10 consecutive business days, with trading continuing uninterrupted on Nasdaq Global Market under symbol UPLD. A second 180-day period may be available if transferred to Nasdaq Capital Market, but success is not assured.

• ·Nasdaq deficiency notice does not currently affect listing or trading.
• ·Company must notify Nasdaq of intent to cure during second compliance period if applicable.
• ·Possible appeal to Nasdaq Hearings Panel if delisting determination issued.
• ·Principal executive offices: 900 S. Capital of Texas Highway, Las Cimas IV, Suite 300, Austin, Texas 78746.

10-04-2026

On April 6, 2026, SPV Facility I LLC, a wholly-owned subsidiary of StepStone Private Credit Fund LLC, and the Company executed a Termination Agreement ending the Loan and Servicing Agreement (MassMutual SPV I Facility) dated April 3, 2023, with no outstanding borrowings at the time following the reinvestment period expiration on April 3, 2026. SPV Facility I paid all remaining fees, resulting in the release of all security interests, liens, and obligations. The termination was clean with no reported financial impact from outstanding debt.

• ·Loan and Servicing Agreement originally dated April 3, 2023
• ·Reinvestment period expired April 3, 2026

10-04-2026

Livento Group, Inc. entered into a financing agreement with AES Capital Management, LLC on September 11, 2025, for $30,000 at 8% interest per annum, with a maturity date of September 11, 2026. The note is convertible into common shares with $0.0001 par value at a price equal to 65% of the average lowest trading price over three discrete trading days. The agreement was filed on April 10, 2026.

• ·Trading symbol: LIVG on OTC Pink
• ·Common stock par value: $0.0001 per share
• ·Company address: 17 State Street, Suite 4000, NY 10004
• ·Former names: NuGene International, Inc. (name change January 27, 2015), Bling Marketing, Inc. (name change December 5, 2013)

10-04-2026

Venture Global, Inc.'s subsidiary, Calcasieu Pass Funding, LLC, closed a $1.75 billion senior secured term loan B credit facility arranged by Goldman Sachs, Barclays, Natixis, and Wells Fargo. A portion of the proceeds was used to fully redeem preferred equity interests previously issued to Stonepeak Bayou Holdings II LP. CEO Mike Sabel stated this transaction reduces the company's cost of capital, strengthens its balance sheet and liquidity, and enhances financial flexibility for strategic priorities.

• ·Filing Date: April 10, 2026
• ·Goldman Sachs served as Lead Left Arranger and Bookrunner; Barclays, Natixis, and Wells Fargo as Lead Right Arrangers and Joint Bookrunners
• ·Latham & Watkins LLP as counsel to Venture Global; Skadden, Arps, Slate, Meagher & Flom LLP as counsel to the arrangers
• ·Venture Global has over 100 MTPA of LNG capacity in production, construction, or development